Page 46 of pharmaceuticals

GlobalData, Rare Diseases, China market, healthcare news, pharma news,

Domestic deals dominate M&A in healthcare and Pharma; Trend to continue in 2023

This year, despite external pressures like the Russian war on Ukraine and COVID-19 fears, major deals in the healthcare and…

January 28, 2023 13:00 IST

Dr. Reddy's, Dr Reddy's labs, Difluprednate Ophthalmic Emulsion, eye drops, eye care, health news, pharma news,

Dr. Reddy’s Laboratories launches eye drops for post-surgery care in United States

The Durezol brand and generic had U.S. sales of approximately $40 million MAT for the most recent twelve months ending in…

January 27, 2023 13:18 IST

Dr. Reddy’s labs PAT up by 77% y-o-y to Rs. 1247 crore in Q3FY23

Meanwhile, revenues during the quarter were up by 27 per cent to Rs 6,770 crore compared to Rs 5,319.7 crore…

January 25, 2023 17:08 IST

Cipla, Cipla q3fy23, healthcare news, pharma news,

Cipla’s profit rises 10 percent y-o-y to Rs. 801 in Q3FY23

Higher 39% YoY driven by on-going clinical trials on a respiratory asset and other developmental efforts continuing including biosimilars, it…

January 25, 2023 16:43 IST

GlobalData, pharmaceuticals, vaccines, omicron variants, covid news, China, health news,

Pharma companies that develop vaccines with efficacy against Omicron variants will gain competitive advantage in China: GlobalData

According to GlobalData’s Pharma Intelligence Center,13 homegrown vaccines have been approved for use against COVID-19 in China.

January 25, 2023 14:38 IST

Rare Diseases, Ministry of Health, Ministry of Finance, Rare Diseases Treatment, Custom Duty, Healthcare news,

Mankind Pharma reduces price of its heart failure drug by 70 percent in India

Studies show that heart failure claims more than 17.9 million lives every year globally whilst, medicines for critically ill heart…

January 25, 2023 12:39 IST

viral infections, OPD cases, seasonal ailments, seasonal flu, health news,

Gland Pharma’s net profit declines 15 percent; Shares hit 52-week low

According to the company’s statement, its margin on earnings before interest, taxes, depreciation, and amortisation slipped to 35 percent from…

January 24, 2023 12:32 IST

Drug Prices, Diabetes, Anxiety, NPPA, healthcare news, pharma news,

Sandoz announces agreement to acquire leading antifungal agent from Astellas

The announcement comes after Sandoz successfully completed the acquisition of GSK’s global cephalosporins portfolio in October 2021.

January 24, 2023 11:40 IST

World Health Organization, WHO, Marion Biotech, Maiden pharmaceuticals, cough syrup, health news, pharma news,

After Gambia and Uzbekistan cough syrup row, WHO urges action to protect children from contaminated medicines

Since these are not isolated incidents WHO calls on various key stakeholders engaged in the medical supply chain to take…

January 24, 2023 11:19 IST

Glenmark Pharmaceuticals, chemotherapy, anti-cancer drug, cancer treatment, healthcare news, pharma news,

Glenmark launches injection to prevent chemotherapy-induced nausea and vomiting in India

The drug is already being marketed in the EU, the US, and Australia.

January 23, 2023 11:23 IST

Eli Lilly, Obesity, USFDA, Alzheimer's drug, Healthcare news, pharma news,

USFDA rejects accelerated approval for Eli Lilly’s Alzheimer’s drug

Lilly said the FDA had sent it a complete response letter for donanemab, an antibody designed to remove amyloid protein…

January 20, 2023 16:36 IST

Dr. Reddy’s reduces price of its heart failure drug

Earlier this week, Novartis’ heart failure drug which is a combination of sacubitril and valsartan lost its patent.

January 20, 2023 12:20 IST

USFDA tentatively approves Alembic Pharmaceuticals’ anti-cancer capsules

The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Calquence Capsules, 100 mg, of AstraZeneca.

January 20, 2023 11:57 IST

Dr. Reddy’s completes clinical studies of its biosimilar for autoimmune disease

The company also informed that its rituximab biosimilar has already been approved for marketing in India and over 25 emerging…

January 20, 2023 11:19 IST

Lupin launches generic version of Novartis’ heart failure drug in India

Studies show that in India, Heart Failure remains one of the most prevalent causes of death in patients suffering from…

January 18, 2023 18:42 IST

Pfizer, Pfizer drug portfolio, healthcare news, pharma news,

Pfizer to sell its full drug portfolio on not-for-profit basis in low-income countries

Reportedly, the programme is aimed at increasing access to innovative treatments in some of the world’s poorest countries.

January 18, 2023 13:33 IST

Obesity, Obesity drugs, semaglutide, cancer, cancer treatment, cancer research, healthcare news, pharma news,

89bio’s drug has potential to become a major player in cholesterol disorder market: GlobalData

According to the analyst consensus forecast on the GlobalData Pharma Intelligence Center, the drug is expected to reach $438 million…

January 17, 2023 14:21 IST

GlobalData, Alzheimer's Disease, Leqembi, Eisai, Biogen, Healthcare news, pharma news,

Leqembi’s prospects in Alzheimer’s disease market remain uncertain despite its advantages over Aduhelm: GlobalData

Leqembi is the second anti-Aβ mAb approved by the FDA for the treatment of Alzheimer’s Disease, following the FDA’s controversial…

January 17, 2023 11:19 IST

Related News

Doshi siblings enter Forbes India Rich List 2025.

India’s newest billionaire siblings: How a solar IPO powered four brothers onto Forbes 2025 Rich List for the first time

Tata Capital IPO share price today, October 13

LIVE: Tata Capital lists at 1.23% premium; JM Financial predicts 10% upside in 12 months

Aadhaar Card update October 2025: Here’s how to change name, address, date of birth and phone number online in simple steps

Sminu Jindal criticised IndiGo for its careless handling of her custom-built wheelchair, adding that it is not “just equipment”, but a symbol of “mobility, independence, and dignity”.

‘What happened with my daughter is deeply concerning,’ Naveen Jindal slams IndiGo over wheelchair incident

Google manager quits Rs 3.4 crore job, says ‘the work was pleasant, but…’

Waaree Renewable Tech soars 14% after Q2 profit doubles – What next for investors?

Market29 min ago

Waaree Renewable Tech saw a 13.5% increase in share price, reaching an all-time high of Rs 1,287 on the NSE. This was driven by a more than doubling of their consolidated net profit to Rs 116.34 crore in Q2 FY26. The company’s strong performance was attributed to robust execution, sectoral tailwinds, and expansion into new energy verticals. Their order book stands at 3.48 GWp.

View all shorts